Dr. Pooja Babbar
Consultant & Unit Head – Medical Oncology
Medical Oncologist
198 verified reviews
198
Recent Consultations
About Dr. Pooja Babbar
Dr. Pooja Babbar is a highly motivated and enthusiastic medical oncologist with over 11 years of experience in the field. She holds a DM in Medical Oncology (Gold Medalist) from the prestigious Kidwai Memorial Institute of Oncology, Rajiv Gandhi University of Health Sciences (RGUHS), where she was awarded a gold medal for her outstanding academic performance.
She has extensive expertise in the evaluation, diagnosis, staging, and formulation of personalised care plans for both solid and haematological malignancies. She remains well-versed with the latest advancements in cancer care, adhering to international protocols and evidence-based guidelines to ensure optimal treatment outcomes.
Dr. Babbar holds a European Certification in Medical Oncology from ESMO and has been trained at Tata Memorial Hospital, Mumbai. Known for her empathetic nature and patient-centric approach, she is committed to delivering comprehensive and holistic oncology care. Her patients trust her for her expertise, compassion, and commitment to cutting-edge cancer treatment.
Conditions Treated by Dr. Pooja Babbar
- Breast cancer
- Lung cancer
- Colorectal cancer
- Gastric cancer
- Gynaecological cancers (ovarian, cervical, endometrial)
- Genitourinary cancers (kidney, bladder, prostate)
- Head and neck cancers
- Lymphoma (Hodgkin and Non-Hodgkin)
- Leukaemia
- Multiple myeloma
Areas of Interest
- Chemotherapy and combination regimens
- Immunotherapy
- Targeted therapy
- Hormonal therapy
- Precision Oncology
- Cancer screening
- Palliative care
- Oncological emergencies
- Multidisciplinary tumour board case discussion
- Haematological malignancies (lymphoma, leukaemia, multiple myeloma)
- Neuro-oncology
- Endocrine and neuroendocrine neoplasm
Qualifications
- MBBS — Maharashtra University of Health Science (MUHS)
- MD Radiation Oncology — Tata Memorial Hospital, Parel, Mumbai
- Senior Residency — Tata Memorial Hospital, Parel, Mumbai
- DM Medical Oncology – Gold Medalist — Kidwai Memorial Institute of Oncology, RGUHS, Bengaluru
- European Certification in Medical Oncology (ESMO) — European Society for Medical Oncology
- Diploma in Medico Legal System — Medical-Legal Institute
- MBA in Hospital Management — Management Institute
Work Experience
- Consultant & Unit Head – Medical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- American Oncology Institute, Gurugram
- CK Birla Hospital, Gurugram
Certifications (2)
DM Medical Oncology – Gold Medalist
Kidwai Memorial Institute of Oncology, RGUHS
European Certification in Medical Oncology
European Society for Medical Oncology (ESMO)
Memberships (3)
- European Society for Medical Oncology (ESMO)
- Indian Society of Medical & Paediatric Oncology (ISMPO)
- Association of Physicians of India
Research Papers & Publications (4)
Cardiotoxic Effect of Chemotherapeutic Agents: Review Article
European Journal of Molecular & Clinical Medicine 2020; 7(10): 3252-3277 — 2020
Carboplatin in Combination with 3-Weekly Paclitaxel as First-Line Therapy in Patients with Recurrent/Metastatic Head-and-Neck Cancers
Oncology Journal of India 2021; 5(2): 71-75 — 2021
Primary Neuroendocrine Tumor of the testis: A rare Case report
Journal of MAR Oncology 2021; 2(5) — 2021
Primary Tracheal Cancer: A Regional Cancer Center Experience
Oncology Journal of India 2021; 5(2): 111-115 — 2021
Procedures
Frequently Asked Questions
Chemotherapy uses cytotoxic drugs that kill rapidly dividing cells, usually given in cycles. Immunotherapy uses the body's own immune system to recognise and destroy cancer cells, typically using checkpoint inhibitors (PD-1/PD-L1 inhibitors). Targeted therapy uses drugs designed to specifically target molecular abnormalities in cancer cells (e.g., HER2-positive breast cancer, EGFR-mutant lung cancer), causing fewer side effects to normal cells. Dr. Babbar will select the most appropriate modality based on the cancer type, molecular profiling, and patient fitness.